COCHNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCHW
Envoy Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.65−0.01 (-2.10%)
Close on Oct 19, 2026
- Market cap
- $68.04M
- P/E (TTM)
- –
- Dividend yield
- –
Envoy Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Orthopedic, Prosthetic & Surgical Appliances & Supplies companies for comparison
Valuation
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Market Cap | $50.49M | $230.55M |
| Enterprise Value | $30.81M | $202.97M |
| PS Ratio | 243.89 | 3.10 |
| PB Ratio | 15.28 | 3.04 |
| P/TBV Ratio | 15.28 | 4.43 |
Enterprise value
| Measure | Envoy Medical | Industry median |
|---|---|---|
| EV / Sales | 148.82 | 2.91 |
Income (trailing twelve months)
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Revenue | $207.00K | $102.39M |
| Gross Profit | -$798.00K | $60.36M |
| Operating Income | -$23.62M | -$4.31M |
| Net Income | -$23.40M | -$6.57M |
| EBITDA | -$23.62M | -$1.98M |
| EPS (Diluted) | -$0.77 | -$0.08 |
Margins
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Gross Margin | -385.5% | 55.2% |
| Operating Margin | -11411.1% | -6.04% |
| Profit Margin | -11304.8% | -10.5% |
| EBITDA Margin | -11411.1% | -2.67% |
Returns
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Return on Assets (ROA) | -138.3% | -13.3% |
| Return on Capital Employed (ROCE) | -208.8% | -9.07% |
Growth
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -6.76% | 8.85% |
| Revenue Growth (3Y CAGR) | 0.56% | 7.08% |
Balance sheet
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $19.68M | $36.66M |
| Net Cash (Debt) | $19.68M | $3.92M |
| Net Cash Per Share | $0.25 | $0.28 |
| Equity (Book Value) | $3.30M | $55.33M |
| Book Value Per Share | $0.04 | $2.87 |
| Tangible Book Value | $3.30M | $10.79M |
| Working Capital | $9.28M | $56.72M |
Financial position
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Current Ratio | 1.73 | 2.48 |
| Quick Ratio | 1.56 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Operating Cash Flow | -$21.53M | -$566.22K |
Efficiency
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.58 |
| Inventory Turnover | 0.63 | 2.21 |
| Revenue Per Employee | $4.81K | $322.92K |
| Profits Per Employee | -$544.21K | -$51.88K |
| Employee Count | 43 | 185 |
Dividends and yields
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Earnings Yield | -46.4% | -6.88% |
| Buyback Yield | -59.8% | 0.78% |
| Shareholder Yield | -59.8% | 0.80% |
Shares
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Shares Outstanding | 77,194,600 | 44,302,700 |
| Shares Change (YoY) | 176.8% | 3.36% |
| Shares Held by Institutions | 39.7% | 63.5% |
Scores
| Measure | Envoy Medical | Industry median |
|---|---|---|
| Altman Z-Score | -20.36 | 1.95 |
| Piotroski F-Score | 2 | 5 |
Calculated by StockData from Envoy Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.